Skip to main content

Find Clinical Trials

Home
Conditions
Inflammatory Breast Cancer

Clinical trial condition

Inflammatory Breast Cancer

Explore clinical trials studying Inflammatory Breast Cancer. Study availability and eligibility vary by location and protocol.

23 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Inflammatory Breast Cancer trial results

Completed

Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer

NCT02324088

Conditions: Breast Diseases, Breast Neoplasms, Inflammatory Breast Cancer, +5 more
Locations: Not specified

View Trial Details

Completed

Denosumab as an add-on Neoadjuvant Treatment (GeparX)

NCT02682693

Conditions: Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +18 more
Locations: Charité Campus Mitte Berlin, Germany

View Trial Details

Completed

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)

NCT01583426

Conditions: Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +19 more
Locations: Helios-Klinikum Berlin-Buch Berlin, Germany

View Trial Details

Completed

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

NCT00513695

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +11 more
Locations: Anchorage Oncology Centre Anchorage, Alaska, United States

Katmai Oncology Group Anchorage, Alaska, United States

Arizona Cancer Center Tucson, Arizona, United States

Saint Luke's Mountain States Tumor Institute Boise, Idaho, United States

View Trial Details

Completed

MUC1 Vaccine for Triple-negative Breast Cancer

NCT00986609

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

NCT02125344

Conditions: Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +18 more
Locations: NTC Heidelberg, Baden-Wurttemberg, Germany

View Trial Details

Completed

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

NCT00003199

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +13 more
Locations: Fred Hutchinson Cancer Research Center/Puget Sound Oncology Consortium Seattle, Washington, United States

View Trial Details

Completed

Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia

NCT00344071

Conditions: Breast Diseases, Breast Neoplasms, Inflammatory Breast Cancer, +5 more
Locations: Cairo University Hospital Cairo, Egypt

National Cancer Institute-Cairo Cairo, Egypt

Association Tunisienne de lutte contre le Cancer (ATCC, le conseil Tunis, Tunisia

Charles Nicolle Hospital, Tunisia Tunis, Tunisia

View Trial Details

Completed

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer

NCT02199418

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +15 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

Shanghai Jiaotong University School of Medicine, Renji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer

NCT01426880

Conditions: Adenocarcinoma, Breast Cancer Female NOS, Breast Diseases, +19 more
Locations: Praxis Dr. Heinrich Fürstenwalde, Brandenburg, Germany

Luisenkrankenhaus Düsseldorf, North Rhine-Westphalia, Germany

NCT Heidelberg Heidelberg, Germany

View Trial Details